

Classification: Synthetic Pentadecapeptide
Active substance: BPC 157 (Body Protecting Compound-157)
Manufacturer: Peptide Hubs
Form/Strength: Lyophilized Powder / 5 mg per vial
Pack size: 2 mL Sterile Vial
Route: Subcutaneous Injection or Oral (after reconstitution)
Lab Test: View Result
Peptide Hubs offers high-purity BPC 157, a renowned synthetic pentadecapeptide celebrated in research for its exceptional ability to promote healing and recovery. Sourced from a body-protecting compound found in gastric juice, our 5mg vials of lyophilized powder are manufactured in a cGMP-compliant facility in the USA. Each batch is independently lab-verified for potency and purity, making it the most reliable choice for researchers looking to buy BPC 157 online. For those seeking an Authentic Peptide Hubs BPC 157 product, our transparent testing is your guarantee.
BPC 157, short for Body Protecting Compound-157, is a stable peptide chain consisting of 15 amino acids. It is derived from a protective protein found in human gastric juice. Unlike many peptides, it is remarkably stable and has shown significant systemic effects in research models, particularly in healing a wide variety of tissues, from tendons and ligaments to the gastrointestinal tract and nervous system. Its mechanism is multifaceted, promoting angiogenesis (new blood vessel formation), cell survival, and collagen deposition.
BPC 157 operates through several key pathways to accelerate the body's natural healing processes. It significantly promotes the formation of granulation tissue, increases collagen production, and enhances blood flow to injured areas. According to a study published in the Journal of Orthopaedic Surgery and Research, it demonstrates strong angiogenic effects, which are crucial for delivering nutrients and oxygen to damaged tissues.
Key research effects of BPC 157 include:
Important: This information is for research purposes only. All dosages discussed are based on common research parameters and are not medical advice.
BPC 157 is typically reconstituted with Bacteriostatic Water. It is unique for its versatility, being effective via both subcutaneous injection and oral administration. For systemic or injury-specific research, a common subcutaneous dosage is 250-500mcg, administered once or twice daily. For gut-specific research, oral administration of 250-500mcg once or twice daily is common. A research cycle typically lasts 4-8 weeks, followed by a break. The 5mg vial provides a substantial supply for a detailed research protocol.
BPC 157 is a cornerstone peptide for any recovery-based research stack. Its systemic healing effects make it synergistic with a wide range of other compounds that promote growth, repair, and performance.
Effective research stacks include:
BPC 157 is widely regarded as extremely safe and well-tolerated in research settings. It is a body-derived compound, which contributes to its low toxicity profile. No significant side effects have been consistently reported in preclinical models. Some anecdotal researcher reports mention a temporary feeling of tiredness as the body directs energy towards healing. As always, the primary risk mitigation strategy is sourcing a pure product from a verified supplier like Peptide Hubs to avoid contaminants.
Choosing our BPC 157 means choosing verifiable quality. We provide a direct link to the third-party lab report confirming each vial contains 5.09mg of peptide with a purity of 99.456%. This transparency ensures researchers are working with a precisely dosed, uncontaminated compound. We offer secure, discreet shipping across the USA and stand behind every product we sell. For researchers dedicated to ethical and accurate study, Peptide Hubs is the definitive source.
Date: 2025-04-22
Result: 5.09 mg; Purity: 99.456%
Subcutaneous injection is typically used for systemic effects or to target specific musculoskeletal injuries (e.g., shoulder, knee). Oral administration is primarily used for targeting gut health and healing the gastrointestinal tract, as it has a direct local effect. Both methods are highly effective for their intended research purposes.
Research timelines vary based on the nature and severity of the condition being studied. Significant results in models of tendon and ligament healing are often observed within 2-4 weeks of consistent administration. For more complex or chronic issues, a research period of 6-8 weeks may be necessary to document conclusive results.
Emerging preclinical research suggests that BPC 157 exhibits neuroprotective properties and may aid in the recovery of nerve damage. It appears to promote the regeneration of nerve cells and protect them from further damage, making it a compound of interest for neurological research. However, more study is required in this area.
Based on its natural origin and existing research, BPC 157 has a very high safety margin. No significant toxicity has been reported in preclinical models, even at doses far exceeding standard research protocols. However, standard research practice involves cycles (e.g., 4-8 weeks on followed by a short break) to prevent any potential receptor desensitization.
The lyophilized (powder) form is stable at room temperature but should be stored in a cool, dark, and dry place. After reconstitution with Bacteriostatic Water, it must be refrigerated (at 36-46°F or 2-8°C) to maintain stability and potency. The reconstituted solution should be used within a few weeks.
Please log in to write BPC 157 5 mg review.
Classification: Research Peptide (Body Protecting Compound)
Active substance: BPC 157 (Pentadecapeptide)
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial (Requires Reconstitution)
Route: Subcutaneous (SubQ) or Near Injury
Lab Test: View Result
Classification: Growth Hormone Secretagogue (GHRP)
Active substance: Ipamorelin
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial
Route: Subcutaneous (SC) Injection
Lab Test: View Result
Classification: Synthetic Melanocortin Peptide
Active substance: Melanotan II
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder / 10 mg per vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection (Reconstituted with Bacteriostatic Water)
Lab Test: View Result
Classification: Metabolic Peptide (GLP-1/GIP Receptor Agonist)
Active substance: Tirzepatide
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection (Reconstitution Required)
Lab Test: View Result
Classification: Nootropic Peptide
Active substance: Semax
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder / 5 mg per 2 mL vial
Pack size: 1 Vial
Route: Intranasal or Subcutaneous
Lab Test: View Result